Condition
Opioid Tolerance
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 3 (1)
Trial Status
Completed2
Terminated1
Unknown1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06488768Not ApplicableRecruiting
Duration of Peripheral Nerve Blocks in Opioid Tolerant Individuals - A Volunteer Blinded Matched Case-control Study
NCT00618397Phase 1Terminated
Pharmacokinetics of Low Dose Ketamine Infusion
NCT01553435Not ApplicableUnknown
Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients
NCT00669175CompletedPrimary
Safety and Efficacy of a Low Dose Naloxone Infusion in NICU Patients
NCT00286052Phase 3CompletedPrimary
Impact of Low Dose Naloxone on Fentanyl Requirements in Pediatric ICU Patients
Showing all 5 trials